美国睡眠专家讲解CBTI 及CBTI和安眠药(Zolpidem)混合治疗失眠的效果区别。两组实验分六个星期、六个月和第二个六个月三个周期。结论是效果最好的失眠治疗是CBTI和安眠药(Zolpidem)混合治疗失眠六个星期,之后维持CBTI六个月。 Video 6 – Insomnia_...
Layout C
美国睡眠专家详细讲解四类安眠药(苯二氮卓类,非苯二氮卓类镇静剂,褪黑激素激动剂,抗抑郁药)治疗失眠的适用范围、半衰期、副作用等;FDA推荐的使用剂量及特别警告;安眠药的国际前沿研究等。 Video 5 – Insomnia_ Sleeping Pills We...
Update 100: Interferon Beta COVID-19 Treatment and a Retrospective Medcram.com wasn’t another medcram video and is turns out the 100th update...
Update 99: Long Haulers – Lingering & Long-Term Symptoms After COVID-19 Medcram.com welcome to another medcram covid-19 update. One of the...
Layout C (slider)
Layout C (combined with D)
美国睡眠专家讲解CBTI 及CBTI和安眠药(Zolpidem)混合治疗失眠的效果区别。两组实验分六个星期、六个月和第二个六个月三个周期。结论是效果最好的失眠治疗是CBTI和安眠药(Zolpidem)混合治疗失眠六个星期,之后维持CBTI六个月。 Video 6 – Insomnia_...
美国睡眠专家详细讲解四类安眠药(苯二氮卓类,非苯二氮卓类镇静剂,褪黑激素激动剂,抗抑郁药)治疗失眠的适用范围、半衰期、副作用等;FDA推荐的使用剂量及特别警告;安眠药的国际前沿研究等。 Video 5 – Insomnia_ Sleeping Pills We...
Layout C 1/2 (combined with D)
美国睡眠专家讲解CBTI 及CBTI和安眠药(Zolpidem)混合治疗失眠的效果区别。两组实验分六个星期、六个月和第二个六个月三个周期。结论是效果最好的失眠治疗是CBTI和安眠药(Zolpidem)混合治疗失眠六个星期,之后维持CBTI六个月。 Video 6 – Insomnia_...
Layout C 1/2 (combined with D)
Update 96: RNA Vaccine; Ivermectin; von Willebrand Factor & COVID-19 Medcram.com what another medcram covid-19 update we have looked at Canada in...
Layout C (combined with G)
Update 96: RNA Vaccine; Ivermectin; von Willebrand Factor & COVID-19 Medcram.com what another medcram covid-19 update we have looked at Canada in...
Update 95: Widespread Thrombosis on Autopsy; Prognostic Factors Medcram.com welcome to another medcram covid-19 update want to let everyone know that...
Layout C (with load more button)
Update 96: RNA Vaccine; Ivermectin; von Willebrand Factor & COVID-19 Medcram.com what another medcram covid-19 update we have looked at Canada in...
Update 95: Widespread Thrombosis on Autopsy; Prognostic Factors Medcram.com welcome to another medcram covid-19 update want to let everyone know that...
Update 94: COVID-19 Treatment with Inhaled Steroids; New Pneumonia in Kazakhstan? 本文由‘中国推动’学者、济南大学生命科学学院生物技术专业任紫豪同学编辑整理。 Welcome to another MedCram...
Update 93: Antibodies, Immunity, & Prevalence of COVID-19 – New Data from Spain 本文由‘中国推动’学者、江南大学药学院石漱新同学编辑整理。 Welcome to another MedCram...
Update 92: COVID-19 & Blood Clots – New Endothelium & Free Radical Research 本文由‘中国推动’学者、济南大学生命科学学院生物技术专业任紫豪同学编辑整理。 It was another...
Update 91: Remdesivir Pricing & Disparities in Drug Availability 本文由‘中国推动’学者、济南大学生命科学学院生物技术专业任紫豪同学编辑整理。 Welcome to another MedCram COVID-19...